drugset / Trial / NCT05671913
Scheduled Intranasal Ketamine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research is to determine if scheduled intranasal ketamine effects opioid requirements in adult trauma patients with moderate to severe pain in the inpatient setting.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2025-12-31
- Completion
- 2026-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | — | Intranasal |
Indications
No indication recorded.